Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.52095 | 72 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.33727 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.48102 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.6746 | 72 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.25379 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.44477 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.79282 | 74 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.52966 | 79 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.82562 | 81 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.19251 | 76 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.54679 | 72 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.98765 | 75 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.46781 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.60665 | 72 |